Abstract:Objective To investigate the impact of using antithrombotic drugs (anticoagulants or antiplatelet aggregation drugs)before the onset of cerebral infarction on hemorrhagic transformation after acute cerebral infarction. Methods The consecutive patients with acute cerebral infarction from Chengdu Stroke Registry Project admitted to the Department of Neurology,West China Hospital,Sichuan University from January 1,2004 to January 1,2014 were enrolled. The baseline data on admission,previous usage of anticoagulants and anti-platelet aggregation drugs,as well as CT/ MRI and other imaging data of all patients were collected. According to the results of CT/ MRI reexamined at 72 h after admission,the patients with hemorrhagic transformation were enrolled into a hemorrhagic transformation group;the patients with non-hemorrhagic transformation were enrolled into a non-hemorrhagic transformation group according to the ratio of 1 ∶ 1. Their gender and age were matched with the hemorrhagic transformation group. The baseline data and drug used of the patients in both groups were compared. The differences of risk factors between the two groups were analyzed with multivariate Logistic regression analysis. The relationship between hemorrhagic transformation and premorbid use of antithrombotic drugs were observed. Results A total of 6 916 patients with acute cerebral infarction were enrolled,including 433 (6. 3%)hemorrhagic transformation (hemorrhagic transformation group)and 433 non-hemorrhagic transformation. (1)There were significant differences between the patients of the two groups on admission in the National Institutes of Health Stroke Scale (NIHSS)score,atrial fibrillation,previous cerebral infarction,and blood glucose levels on admission (all P < 0. 05). (2)The proportions of using anticoagulants and antiplatelet aggregation agents in the hemorrhagic transformation group were higher than those of the non-hemorrhagic transformation group (anticoagulants:14. 1% [n = 61]vs. 3. 9% [n = 17];P < 0. 01,OR,4. 01,95% CI 2. 303 -6. 993;anti-platelet aggregation drugs:14. 3% [n =62]vs. 8. 3% [n = 36];P = 0. 005,OR,1. 84,95% CI 1. 194 -2. 846). (3)The results of multivariate Logistic regression analysis showed that the use of anticoagu-lants,anti-platelet aggregation drugs,NIHSS score on admission,and random blood glucose on admission were the independent risk factors for hemorrhagic transformation (OR [95% CI]3. 302 [1. 860 -5. 862], 2. 081 [1. 281 -3. 382],1. 047 [1. 026 -1. 069],and 1. 055 [1. 011 -1. 100],respectively (all P <0. 05). Conclusion The NIHSS score and blood glucose levels on admission are the independent risk factors of hemorrhagic transformation. Using anticoagulants or anti-platelet aggregation drugs before symptom onset is independently associated with hemorrhagic transformation,however,its relationship with the long-term prognosis of acute cerebral infarction need to be further studied.

Predictive Value of Cerebral Microbleeds for Early Hemorrhagic Transformation in Non-lacunar Infarction Patients with Antithrombotic Therapy

[Impact of Cerebral Microbleeds on Outcomes of Acute Ischemic Stroke Treated with Intravenous Thrombolysis].

Clinical Outcome in Acute Ischemic Stroke Patients with Microbleeds after Thrombolytic Therapy A Meta-Analysis

Extensive Cerebral Microbleeds Predict Parenchymal Haemorrhage and Poor Outcome after Intravenous Thrombolysis

Microbleeds, Cerebral Hemorrhage, and Functional Outcome After Stroke Thrombolysis.

[Safety of Intravenous Thrombolysis in Cerebral Microbleeds Patients with Prior Antiplatelet Therapy].

Predicting Hemorrhagic Transformation after Thrombectomy in Acute Ischemic Stroke: a Multimodal Score of the Regional Pial Collateral

Cerebral Microbleeds Do Not Predict Hemorrhagic Transformation in Acute Ischemic Stroke Patients with Atrial Fibrillation And/or Rheumatic Heart Disease.

Alberta stroke programme early CT score on diffusion-weighted imaging and clot burden scoring on MR angiography in the prediction of hemorrhagic transformation after thrombolysis in acute cerebral infarction

Key CT Markers for Predicting Haemorrhagic Transformation after Ischaemic Stroke: a Prospective Cohort Study in China

Mechanical thrombectomy for acute ischemic stroke with cerebral microbleeds.

Research progress on the value of CT and MRI in predicting hemorrhagic transformation after acute ischemic stroke

Prior Antithrombotic Therapy is Associated with Cerebral Microbleeds in Ischemic Stroke Patients with Atrial Fibrillation and/or Rheumatic Heart Disease (P4.3-062)

Correlative Study of the Relationship Between Hemorrhagic Transformation and Premorbid Antithrombotic Therapy after Acute Cerebral Infarction

The relevant risk factors for analyzing the occurrence and distribution of cerebral microbleedsin old patients with transient ischemic attack

Risk factors of cerebral microbleeds in patients with ischemic cerebrovascular disease

Correlation between antiplatelet therapy in secondary prevention of acute cerebral infarction and cerebral microbleeds: A susceptibility-weighted imaging (SWI) study.

Prior Antithrombotic Therapy is Associated with Cerebral Microbleeds in Ischemic Stroke Patients with Atrial Fibrillation And/or Rheumatic Heart Disease

High-sensitivity Cardiac Troponin T Levels and Risk of Cerebral Microbleeds in Acute Ischemic Stroke Patients with Atrial Fibrillation And/or Rheumatic Heart Disease

Influence of cerebral microbleeds on mechanical thrombectomy outcomes

Abstract TP245: Prediction of Hemorrhagic Transformation in Patients with Acute Ischaemic Stroke and Atrial Fibrillation with Ct Perfusion Aspects Scores